ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients.
Dingxie LiuQiongyu HaoJieqing LiQun LiKun WangQing GengYutong WuJaydutt V VadgamaYong WuPublished in: Cancer communications (London, England) (2022)